Free Trial

Vaccine Concerns Weigh on ZAR as SONA Comes Into View

SOUTH AFRICA
  • USD/ZAR 0.28% higher at the open as concerns over vaccines dampen sentiment slightly.
  • The cross remains choppy around the 14.90 level that tentatively broke on the back of Friday's NFPs that sparked a bout of risk on, but not enough to confirm a resumption of the downtrend.
  • Focus this week on vaccine developments and Thurday's SONA.
  • Markets likely to be a bit disappointed in a typical SA SONA packed with dreams, but light on credible reform promises with the Feb 24 budget acting as a better future performance indicator.
  • Outside of that, the cross should be dominated by global risk sentiment & US CPI data. A clean break of Friday's low (14.83) is needed to take the next leg lower.
  • Commodities slightly firmer on weaker greenback (gold + 0.15% , Platinum +1.91%).
  • Res1 : 14.9078, Res2: 15.00, Sup1: 14.8337, Sup2: 14.7855
MNI London Bureau | +44 020-3983-7894 | murray.nichol@marketnews.com
MNI London Bureau | +44 020-3983-7894 | murray.nichol@marketnews.com

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.